SCHEMBL29937677

SCHEMBL29937677

COc1cc(Br)cc2c1CCCC2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
CYP3A4 P08684 2/20 0.38
KDM4E B2RXH2 2/20 0.38
NQO2 P16083 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ERN1 O75460 2/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CETP P11597 1/20 0.35
ACHE P22303 1/20 0.34
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22618647 1.00 MAPT (0.40) MAPTCYP3A4KDM4ENQO2CYP1A2
SCHEMBL29383412 0.96 NQO2 (0.38) MAPTCYP3A4KDM4ENQO2CYP1A2
SCHEMBL22618628 0.96 NQO2 (0.38) MAPTCYP3A4KDM4ENQO2CYP1A2
SCHEMBL10351350 0.80 HTR2C (0.57) HTR2AHTR2CHTR2B
SCHEMBL10351343 0.80 MAOA (0.50) CYP1A2GAATDP1
SCHEMBL28702513 0.78 CFD (0.43) MAPTKDM4ECYP1A2MEN1KMT2A
SCHEMBL22858683 0.75 HTR2C (0.51) HTR2AHTR2CHTR2B
SCHEMBL29608060 0.75 HTR2C (0.51) HTR2AHTR2CHTR2B
SCHEMBL29507128 0.75 HTR2C (0.47) HTR2AHTR2CHTR2B
SCHEMBL22858977 0.75 HTR2C (0.47) HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113574058-B Indole macrocyclic derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2024-04-16 CN disclosed
CN-112533929-B Indole macrocyclic derivatives, preparation method and medical application thereof 福建盛迪医药有限公司 2022-09-16 CN disclosed